for educational and safety purposes
Every compound in the sci-wiki that affects insulin receptors; the ones you can source are floated to the front, then the reference-only entries. Tap any for the full entry, mechanism, and outlets.
2 sourced · 0 reference
Insulin aspart is a rapid-acting insulin analog used to control blood sugar in people with type 1 and type 2 diabetes. It is a laboratory-modified form of human insulin in which the amino acid proline at position B28 is replaced by aspartic acid, a change that makes the insulin absorb and act more quickly than regular human insulin. Developed by Novo Nordisk and sold under names such as NovoLog and NovoRapid, it is taken at mealtimes and is listed by the World Health Organization as an essential medicine.
Insulin glargine is a long-acting, or basal, insulin analog used to provide a steady background level of insulin in people with type 1 and type 2 diabetes. It is a modified human insulin engineered to dissolve slowly after injection, releasing insulin at a relatively flat rate over roughly a day so that a single daily dose can cover the body's baseline needs. First approved in 2000 and originally sold as Lantus, it is now available in several brands and biosimilars and appears on the World Health Organization list of essential medicines.